Adjunctive Transdermal Cannabidiol for Adults With Focal Epilepsy: A Randomized Clinical Trial

IMPORTANCE: Cannabidiol has shown efficacy in randomized clinical trials for drug-resistant epilepsy in specific syndromes that predominantly affect children. However, high-level evidence for the efficacy and safety of cannabidiol in the most common form of drug-resistant epilepsy in adults, focal e...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Brien, Terence J., Berkovic, Samuel F., French, Jacqueline A., Messenheimer, John A., Sebree, Terri B., Bonn-Miller, Marcel O., Gutterman, Donna L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270696/
https://www.ncbi.nlm.nih.gov/pubmed/35802375
http://dx.doi.org/10.1001/jamanetworkopen.2022.20189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270696/
https://www.ncbi.nlm.nih.gov/pubmed/35802375
http://dx.doi.org/10.1001/jamanetworkopen.2022.20189

Ejemplares similares